Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Nitric oxide-donating atorvastatin attenuates neutrophil recruitment during vascular inflammation independent of changes in plasma cholesterol.

Baetta R, Granata A, Miglietta D, Oliva F, Arnaboldi L, Bonomo A, Ferri N, Ongini E, Bellosta S, Corsini A.

Cardiovasc Drugs Ther. 2013 Jun;27(3):211-9. doi: 10.1007/s10557-013-6445-1.

PMID:
23400638
3.

NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties.

Momi S, Impagnatiello F, Guzzetta M, Caracchini R, Guglielmini G, Olivieri R, Monopoli A, Gresele P.

Eur J Pharmacol. 2007 Sep 10;570(1-3):115-24. Epub 2007 Jun 5.

PMID:
17632098
4.

Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels.

Bot I, Jukema JW, Lankhuizen IM, van Berkel TJ, Biessen EA.

Atherosclerosis. 2011 Feb;214(2):295-300. doi: 10.1016/j.atherosclerosis.2010.11.008. Epub 2010 Nov 13.

5.

Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis.

Momi S, Monopoli A, Alberti PF, Falcinelli E, Corazzi T, Conti V, Miglietta D, Ongini E, Minuz P, Gresele P.

Cardiovasc Res. 2012 Jun 1;94(3):428-38. doi: 10.1093/cvr/cvs100. Epub 2012 Feb 23.

PMID:
22362817
6.

Thyroid hormone beta receptor activation has additive cholesterol lowering activity in combination with atorvastatin in rabbits, dogs and monkeys.

Ito BR, Zhang BH, Cable EE, Song X, Fujitaki JM, MacKenna DA, Wilker CE, Chi B, van Poelje PD, Linemeyer DL, Erion MD.

Br J Pharmacol. 2009 Feb;156(3):454-65. doi: 10.1111/j.1750-3639.2009.00038.x. Epub 2009 Jan 22.

7.

Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.

Ajamieh H, Farrell G, Wong HJ, Yu J, Chu E, Chen J, Teoh N.

J Gastroenterol Hepatol. 2012 Aug;27(8):1353-61. doi: 10.1111/j.1440-1746.2012.07123.x.

PMID:
22432744
8.

Atorvastatin improves plaque stability in ApoE-knockout mice by regulating chemokines and chemokine receptors.

Nie P, Li D, Hu L, Jin S, Yu Y, Cai Z, Shao Q, Shen J, Yi J, Xiao H, Shen L, He B.

PLoS One. 2014 May 9;9(5):e97009. doi: 10.1371/journal.pone.0097009. eCollection 2014.

9.

Add-on effect of probucol in atherosclerotic, cholesterol-fed rabbits treated with atorvastatin.

Keyamura Y, Nagano C, Kohashi M, Niimi M, Nozako M, Koyama T, Yasufuku R, Imaizumi A, Itabe H, Yoshikawa T.

PLoS One. 2014 May 8;9(5):e96929. doi: 10.1371/journal.pone.0096929. eCollection 2014.

10.

Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbits.

Niimi M, Keyamura Y, Nozako M, Koyama T, Kohashi M, Yasufuku R, Yoshikawa T, Fan J.

Lipids Health Dis. 2013 Nov 4;12:166. doi: 10.1186/1476-511X-12-166.

11.

Nitric oxide-donating statin improves multiple functions of circulating angiogenic cells.

Mangialardi G, Monopoli A, Ongini E, Spinetti G, Fortunato O, Emanueli C, Madeddu P.

Br J Pharmacol. 2011 Sep;164(2b):570-83. doi: 10.1111/j.1476-5381.2011.01423.x.

12.

Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia.

Kastelein JJ, van Leuven SI, Burgess L, Evans GW, Kuivenhoven JA, Barter PJ, Revkin JH, Grobbee DE, Riley WA, Shear CL, Duggan WT, Bots ML; RADIANCE 1 Investigators..

N Engl J Med. 2007 Apr 19;356(16):1620-30. Epub 2007 Mar 26.

13.

Effect of atorvastatin on endothelium-dependent vasodilation in postmenopausal women with average serum cholesterol levels.

Mercuro G, Zoncu S, Saiu F, Sarais C, Rosano GM.

Am J Cardiol. 2002 Oct 1;90(7):747-50.

PMID:
12356389
14.

Role of microRNAs 221/222 on statin induced nitric oxide release in human endothelial cells.

Cerda A, Fajardo CM, Basso RG, Hirata MH, Hirata RD.

Arq Bras Cardiol. 2015 Mar;104(3):195-201. doi: 10.5935/abc.20140192. Epub 2014 Dec 16. English, Portuguese.

15.

Statins alter neutrophil migration by modulating cellular Rho activity--a potential mechanism for statins-mediated pleotropic effects?

Maher BM, Dhonnchu TN, Burke JP, Soo A, Wood AE, Watson RW.

J Leukoc Biol. 2009 Jan;85(1):186-93. doi: 10.1189/jlb.0608382. Epub 2008 Oct 7.

PMID:
18840670
16.

Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications.

Tikoo K, Patel G, Kumar S, Karpe PA, Sanghavi M, Malek V, Srinivasan K.

Biochem Pharmacol. 2015 Feb 1;93(3):343-51. doi: 10.1016/j.bcp.2014.11.013. Epub 2014 Dec 4.

PMID:
25482567
17.

Nitric oxide prevents atorvastatin-induced skeletal muscle dysfunction and alterations in mice.

D'Antona G, Mascaro A, Monopoli A, Miglietta D, Ongini E, Bottinelli R.

Muscle Nerve. 2013 Jan;47(1):72-80. doi: 10.1002/mus.23465. Epub 2012 Oct 5.

PMID:
23042511
18.

Effect of minocycline on carotid atherosclerotic plaques.

Gao J, Gao X, Pan S.

Neurol Res. 2013 Oct;35(8):844-50. doi: 10.1179/1743132813Y.0000000223. Epub 2013 May 14.

PMID:
23676309
19.

Atorvastatin attenuates inflammatory infiltration and vascular remodeling in lung of hypercholesterolemia rabbits.

Duan S, Zhang Y, Wu SJ, Jiang LZ, Zhang J, Gan Y, Chen P, Zhao SP, Li GY.

Exp Lung Res. 2010 Dec;36(10):573-92. doi: 10.3109/01902141003739715.

PMID:
21043990
20.

Biphasic effects of atorvastatin on inflammation.

Garjani A, Andalib S, Ziaee M, Maleki-Dizaji N.

Pak J Pharm Sci. 2008 Apr;21(2):125-30.

PMID:
18390442

Supplemental Content

Support Center